About usOur teamOur pipelineContact us

Investors

annual reportS

September 2022

RAD Annual Report June 2022

Download
September 2022

RAD ESG Report 2022

Download

shareholder newsletter

May 2023

Radiopharm Newsletter 1st Quarter 2023

Download
December 2022

Radiopharm Newsletter December 2022

Download
July 2022

Radiopharm Newsletter July 2022

Download
March 2022

Radiopharm Newsletter March 2022 - Meet our CEO in Australia

Download

ANalyst coverage

February 2023

Diamond Equity Research update Valuation at 70 cents per share

Download
December 2022

Diamond Equity Research update Valuation to 70 cents per share

Download
August 2022

Diamond Equity Research increases Valuation to 88 cents per share

Download
June 2022

Bioshares RAD Update 17 June 2022

Download

corporate governance

Radiopharm Theranostics Prospectus and Supplementary Disclaimers

Download

Radiopharm Theranostics Prospectus

Download

Radiopharm Theranostics Supplementary Prospectus

Download

Corporate Governance

Download

corporate policies

Privacy Policy

Download

Sign up to our mailing list.

Receive all the latest news from Radiopharm Theranostics.